Anna Papazoglou

Anna Papazoglou

Auto-generated profile, based on publicly available information

Anna Papazoglou

Department of Pediatrics, University General Hospital of Alexandroupolis

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2016 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
APAnna Papazoglou
Anna Papazoglou
ALAndreas Lundt
Andreas Lundt
CWCarola Wormuth
Carola Wormuth
DEDan Ehninger
Dan Ehninger
CHChristina Henseler
Christina Henseler
MWMarco Weiergräber
Marco Weiergräber
Implantable EEG radiotelemetry is of central relevance in the neurological characterization of transgenic mouse models of neuropsychiatric and neurodegenerative diseases as well as epilepsies. This powerful technique does not only provide valuable insights into the underlying pathophysiological mechanisms, i.e., the etiopathogenesis of CNS related diseases, it also facilitates the development of new translational, i.e., therapeutic approaches. Whereas competing techniques that make use of recorder systems used in jackets or tethered systems suffer from their unphysiological restraining to semi-restraining character, radiotelemetric EEG recordings overcome these disadvantages. Technically, implantable EEG radiotelemetry allows for precise and highly sensitive measurement of epidural and deep, intracerebral EEGs under various physiological and pathophysiological conditions. First, we present a detailed protocol of a straight forward, successful, quick and efficient technique for epidural (surface) EEG recordings resulting in high-quality electrocorticograms. Second, we demonstrate how to implant deep, intracerebral EEG electrodes, e.g., in the hippocampus (electrohippocampogram). For both approaches, a computerized 3D stereotaxic electrode implantation system is used. The radiofrequency transmitter itself is implanted into a subcutaneous pouch in both mice and rats. Special attention also has to be paid to pre-, peri- and postoperative treatment of the experimental animals. Preoperative preparation of mice and rats, suitable anesthesia as well as postoperative treatment and pain management are described in detail.

9 June 2023 in Pediatric Hematology Oncology Journal
Verified
Journal Article
Open access
SASonia Alexiadou
Sonia Alexiadou
APAnna Papazoglou
Anna Papazoglou
EMElpis Mantadakis
Elpis Mantadakis

1 August 2025 in Brazilian Journal of Case Reports
Verified
Journal Article
Open access
PDF file
MMMurat Mustafa
Murat Mustafa
SASonia Alexiadou
Sonia Alexiadou
STStavros Thomaidis
Stavros Thomaidis
APAnna Papazoglou
Anna Papazoglou
AGAnastasia Grapsa
Anastasia Grapsa
EMElpis Mantadakis
Elpis Mantadakis
We describe a male toddler with a history of operated posterior urethral valves who developed vitamin D toxicity with hypercalcemia after he was prescribed orally 6,000 IU of cholecalciferol daily for two months for vitamin D deficiency. The disordered calcium metabolism was discovered during hospitalization in our hospital for a urinary tract infection, along with evidence of renal failure. Serum calcium on admission was 4.22 mmol/L, with an ionized calcium level of 2.26 mmol/L. The measured 25(OH)D level was extremely high (3,555 ng/mL), along with a low serum parathyroid hormone, suggestive of severe vitamin D overdose. Despite aggressive hydration, administration of corticosteroids, and a low calcium diet, he required the administration of a single dose of zoledronic acid for resolution of the hypercalcemia. It was later discovered that the patient received an oral solution of vitamin D3 that was recalled due to a higher content of vitamin D3 than stated on its label. Therapy with low-dose bisphosphonates is effective in cases of symptomatic hypercalcemia that does not respond to intravenous hydration, administration of corticosteroids, and elimination of oral calcium intake. Any child presenting with hypercalcemia and low parathyroid hormone should be investigated for the possibility of vitamin D toxicity.